{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:31:56Z","timestamp":1770741116527,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007941","name":"Addis Ababa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007941","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12886-018-0868-1","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T09:20:04Z","timestamp":1533547204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study"],"prefix":"10.1186","volume":"18","author":[{"given":"Zelalem","family":"Tilahun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teferi Gedif","family":"Fenta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"868_CR1","unstructured":"WHO. WHO Alliance for Global Elimination of Blinding Trachoma by 2020: Weekly epidemiological record 2014; 39(89):421\u2013428."},{"key":"868_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/bjo.2008.148494","volume":"93","author":"SP Mariotti","year":"2009","unstructured":"Mariotti SP, Pascolini D, Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol. 2009;93:563\u20138.","journal-title":"Br J Ophthalmol"},{"key":"868_CR3","unstructured":"Carter Center. Summary Proceedings: Eleventh Annual Trachoma Control Program Review; Planning for Trachoma Elimination, District by District; 2010.URL: \n                    http:\/\/www.cartercenter.org\/resources\/pdfs\/news\/health_publications\/trachoma\/trachreview_final_eng2010.pdf\n                    \n                   (Accessed on December 2012)."},{"key":"868_CR4","unstructured":"FMOH. National survey on blindness, Low Vision and Trachoma in Ethiopia; 2006. \n                    http:\/\/pbunion.org\/Countriessurveyresults\/Ethiopia\/Ethiopian_National_Blindness_and_trachoma_survey.pdf\n                    \n                   (Accessed on 05 DeC 2012)."},{"key":"868_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/bjo.64.1.37","volume":"64","author":"S Darougar","year":"1980","unstructured":"Darougar S, Jones BR, Viswalingam M, et al. Topical therapy of hyper endemic trachoma with rifampicin, oxytetracycline or spiramycin eye ointments. Br J Ophthalmol. 1980;64:37\u201342.","journal-title":"Br J Ophthalmol"},{"key":"868_CR6","first-page":"347","volume":"60","author":"CR Dawson","year":"1982","unstructured":"Dawson CR, Daghfous T, Hoshiwara I, et al. Trachoma therapy with topicaltetracycline and oral erythromycin: a comparative trial. Bull World Health Organ. 1982;60:347\u201355.","journal-title":"Bull World Health Organ"},{"key":"868_CR7","first-page":"55","volume":"12","author":"SK West","year":"1999","unstructured":"West SK, Solomon AW. Azithromycin for control of trachoma. Community Eye Health. 1999;12:55\u20136.","journal-title":"Community Eye Health"},{"key":"868_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0140-6736(93)91591-9","volume":"342","author":"RL Bailey","year":"1993","unstructured":"Bailey RL, Arullendran P, Whittle HC, Mabey DC. Randomized controlled trial of single-dose azithromycin in treatment of trachoma. Lancet. 1993;342:453\u20136.","journal-title":"Lancet"},{"key":"868_CR9","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1056\/NEJMoa040979","volume":"351","author":"AW Solomon","year":"2004","unstructured":"Solomon AW, Holland MJ, Alexander NDE, Massae PA, Aguirre A, Natividad-Sancho A, Molina S, Safari S, Shao JF, Courtright P, Peeling RW, West SK, Bailey RL, Foster A, Mabey DC. Mass treatment with single dose azithromycin for trachoma. N Engl J Med. 2004;351:1962\u201371.","journal-title":"N Engl J Med"},{"key":"868_CR10","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMc0706263","volume":"358","author":"AW Solomon","year":"2008","unstructured":"Solomon AW, Harding-Esch E, Alexander ND, Aguirre A, Holland MJ, Bailey RL, Foster A, Mabey DC, Massae PA, Courtright P, Shao JF. Two doses of azithromycin to eliminate trachoma in a Tanzanian community. New Engl J Med. 2008;358:1870\u20131.","journal-title":"New Engl J Med"},{"key":"868_CR11","doi-asserted-by":"publisher","unstructured":"Coles CL, Seidman JC, Levens J, Mkocha H, Munoz B, West S. Association of Mass Treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children. Am J Trop Med Hyg. 2011; \n                    https:\/\/doi.org\/10.4269\/ajtmh.2011.11-0046\n                    \n                  .","DOI":"10.4269\/ajtmh.2011.11-0046"},{"key":"868_CR12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/cid\/cir069","volume":"52","author":"JD Keenan","year":"2011","unstructured":"Keenan JD, Ayele B, Gebre T, Zerihun M, Zhou Z, House JI, Gaynor BD, Porco TC, Emerson PM, Lietman TM. Childhood mortality in a cohort treated with mass azithromycin for trachoma. Clin Infect Dis. 2011;52:883\u20138.","journal-title":"Clin Infect Dis"},{"key":"868_CR13","first-page":"632","volume":"79","author":"N Fraser-Hurt","year":"2001","unstructured":"Fraser-Hurt N, Bailey RL, Cousens S, Mabey D, Faal H, Mabey DCW. Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma. Bull World Health Organ. 2001;79:632\u201340.","journal-title":"Bull World Health Organ"},{"key":"868_CR14","unstructured":"WHO. World Health Assembly Resolution 51.11 Global Elimination of blinding trachoma; 1998. \n                    http:\/\/www.who.int\/neglected_diseases\/mediacentre\/WHA_51.11_Eng.pdf\n                    \n                  . Accessed 30 Nov 2012."},{"key":"868_CR15","volume-title":"Joint Research Agenda Meeting for the Elimination of Blinding Trachoma","author":"WHO-ITI","year":"2004","unstructured":"WHO-ITI. Joint Research Agenda Meeting for the Elimination of Blinding Trachoma. Geneva: World Health. Organization; 2004."},{"key":"868_CR16","doi-asserted-by":"publisher","unstructured":"Ssemanda EN, Levens J, Mkocha H, Munoz B, West SK. Azithromycin Mass Treatment for Trachoma Control: Risk Factors for Non-Participation of Children in Two Treatment Rounds. PLoS Negl Trop Dis. 2012; \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0001576\n                    \n                  .","DOI":"10.1371\/journal.pntd.0001576"},{"key":"868_CR17","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/jama.292.6.721","volume":"292","author":"M Melese","year":"2004","unstructured":"Melese M, Chidambaram JD, Alemayehu W, Lee DC, Yi EH, Cevallos V, Zhou Z, Donnellan C, Saidel M, Whitcher JP, Gaynor BD, Lietman TM. Feasibility of eliminating ocular chlamydia trachomatis with repeat mass antibiotic treatments. Jama. 2004;292:721\u20135.","journal-title":"Jama"},{"key":"868_CR18","unstructured":"University of Twente. Health Belief Model; 2013. \n                    https:\/\/www.utwente.nl\/en\/bms\/communication-theories\/sorted-bycluster\/Health%20Communication\/Health_Belief_Model\/\n                    \n                  . Accessed 28 June 2013."},{"key":"868_CR19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.trstmh.2005.03.006","volume":"99","author":"N Desmond","year":"2005","unstructured":"Desmond N, Solomon AW, Massae PA, Lema N, Anemona A, Foster A, Mabey DW. Acceptability of azithromycin for the control of trachoma in northern Tanzania. Trans R Soc Trop Med Hyg. 2005;99:656\u201363.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"868_CR20","first-page":"1","volume-title":"Sample size determination for health studies: a practical manual","author":"SK Lwanga","year":"1991","unstructured":"Lwanga SK, Lemeshow S. Sample size determination for health studies: a practical manual. Geneva: World Health Organization; 1991. p. 1\u20135."},{"key":"868_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002115","volume":"7","author":"EM Harding-Esch","year":"2013","unstructured":"Harding-Esch EM, Sillah A, Edwards T, Burr SE, Hart JD, Joof H, Laye M, Makalo P, Ahmed M, Molina S, Sarr-Sissoho I, Quinn TC, Lietman T, Holland MJ, Mabey D, West SK, Robin B. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia. PLoS Negl Trop Dis. 2013;7:e2115. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0002115\n                    \n                  .","journal-title":"PLoS Negl Trop Dis"},{"key":"868_CR22","unstructured":"Central Statistics Authority. Summary and Statistical Report of the 2007 Population and Housing Census. 2008, Addis Ababa. \n                    https:\/\/searchworks.stanford.edu\/view\/8650186\n                    \n                  . Accessed 12 Dec 2012."},{"key":"868_CR23","doi-asserted-by":"publisher","first-page":"e1995","DOI":"10.1371\/journal.pntd.0001995","volume":"7","author":"EA Cromwell","year":"2013","unstructured":"Cromwell EA, King JD, McPherson S, Jip FN, Patterson AE, Mosher AW, Evans DS, Emerson PM. Monitoring of mass distribution interventions for trachoma in plateau state, Nigeria. PLoS Negl Trop Dis. 2013;7:e1995. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0001995\n                    \n                  .","journal-title":"PLoS Negl Trop Dis"},{"key":"868_CR24","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/infdis\/143.6.853","volume":"143","author":"RR Malaty","year":"1981","unstructured":"Malaty RR, Zaki SS, Said ME, Vastine DW, Dawson DW, Schachter J. Extra ocular infections in children in areas with endemic trachoma. J Infect Dis. 1981;143:853.","journal-title":"J Infect Dis"},{"key":"868_CR25","doi-asserted-by":"publisher","first-page":"e401","DOI":"10.1371\/journal.pntd.0000401","volume":"3","author":"IM Blake","year":"2009","unstructured":"Blake IM, Burton MJ, Bailey RL, Solomon AW, West S, Munoz B, Holland MJ, Mabey DCW, Gambhir M, Basanez MG, Grassly NC. Estimating household and community transmission of ocular chlamydia trachomatis. PLoS Negl Trop Dis. 2009;3:e401. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0000401\n                    \n                  .","journal-title":"PLoS Negl Trop Dis"},{"key":"868_CR26","doi-asserted-by":"publisher","first-page":"e376","DOI":"10.1371\/journal.pntd.0000376","volume":"3","author":"T Lakew","year":"2009","unstructured":"Lakew T, House J, Hong KC, Yi E, Alemayehu W, Melese M, Zhou Z, Ray K, Chin S, Romero E, Keenan J, Whitcher JP, Gaynor BD, Lietman TM. Reduction and return of infectious trachoma in severely affected communities in Ethiopia. PLoS Negl Trop Dis. 2009;3:e376. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0000376\n                    \n                  .","journal-title":"PLoS Negl Trop Dis"},{"key":"868_CR27","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1371\/journal.pntd.0000341","volume":"2","author":"NC Grassly","year":"2008","unstructured":"Grassly NC, Ward ME, Ferris S, Mabey DC, Bailey RL. The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up. PLoS Negl Trop Dis. 2008;2:e341. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0000341\n                    \n                  .","journal-title":"PLoS Negl Trop Dis"},{"key":"868_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/bjo.83.2.134","volume":"83","author":"KI Taylor","year":"1999","unstructured":"Taylor KI, Taylor HR. Distribution of azithromycin for the treatment of trachoma. Br J Ophthalmol. 1999;83:134\u20135.","journal-title":"Br J Ophthalmol"},{"key":"868_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4269\/ajtmh.2011.11-0056","volume":"85","author":"B Ayele","year":"2011","unstructured":"Ayele B, Gebre T, House JI, Zhou Z, McCulloch CE, Porco TC, Gaynor BD, Emerson PM, Lietman TM, Keenan JD. Short report: adverse events after mass azithromycin treatments for trachoma in Ethiopia. Am J Trop Med Hyg. 2011;85:291\u20134.","journal-title":"Am J Trop Med Hyg"},{"key":"868_CR30","unstructured":"FDA. United states Food and Drug Administration safety announcement; 2013. \n                    https:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM343347.pdf\n                    \n                  . Accessed Dec 2013."},{"key":"868_CR31","doi-asserted-by":"publisher","unstructured":"Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the Risk of Cardiovascular Death. N Engl J Med. 2012; \n                    https:\/\/doi.org\/10.1056\/NEJMoa1003833\n                    \n                  .","DOI":"10.1056\/NEJMoa1003833"},{"key":"868_CR32","doi-asserted-by":"publisher","unstructured":"Bin Abdulhak AA, Khan AR, Garbati MA, Qazi AH, Erwin P, Kisra S, Aly A, Farid T, ElChamiM WAP. Azithromycin and risk of cardiovascular death: a Meta analytic review of observational studies. Am J Ther. 2015; \n                    https:\/\/doi.org\/10.1097\/MJT.0000000000000138\n                    \n                  .","DOI":"10.1097\/MJT.0000000000000138"},{"key":"868_CR33","doi-asserted-by":"publisher","unstructured":"Alemayehu D, Andrews EN, Glue P, Knirsch CA. Considerations for the design and conduct of a pharmacovigilance study involving mass drug Administration in a Resource-Constrained Setting. PLoS Negl Trop Dis. 2010; \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0000564\n                    \n                  .","DOI":"10.1371\/journal.pntd.0000564"},{"key":"868_CR34","doi-asserted-by":"publisher","unstructured":"Amarillo MLE, Belizario VY, Sadiang-abay JT, Sison SAM, Dayag AMS. Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines. Parasit Vectors. 2008;1:14. \n                    https:\/\/doi.org\/10.1186\/1756-3305-1-14\n                    \n                  .","DOI":"10.1186\/1756-3305-1-14"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-018-0868-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-018-0868-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-018-0868-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T23:38:01Z","timestamp":1569195481000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-018-0868-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["868"],"URL":"https:\/\/doi.org\/10.1186\/s12886-018-0868-1","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"assertion":[{"value":"16 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Before the study began, all procedures and methods planned was reviewed and approved by the Ethics Review Committee of the School of Pharmacy, Addis Ababa. Then, official letter was written from the Department of Pharmaceutics and Social Pharmacy to Amhara Regional Health Bureau to get permission for conducting the study. The purpose of the study was clearly explained to all study participants, and verbal informed consent was obtained from each participant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}},{"value":"All authors declared that there are no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"193"}}